“Anterior Chamber Depth After Phacovitrectomy” – Response to Letter to the Editor [Response to Letter]

Katz, Gabriel; Zhalka, Fidaa El; Veksler, Ronel; Ayalon, Anfisa; Moisseiev, Elad

doi:10.2147/opth.s324737

Search citation statements

Order By: Relevance

Paper Sections

Select...

The Fda Recommendation1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2023

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

(1 citation statement)

References 5 publications

(9 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…FDA rejected this submission, expressing safety concerns about next-day driving specific to the dosing regimen of Intermezzo (Katz, 2009). Because patients were meant to take Intermezzo in the middle of the night, they would have less time between their dose of zolpidem and next-day driving.…”

Section: The Fda Recommendationmentioning

confidence: 99%

Making a ‘sex-difference fact’: Ambien dosing at the interface of policy, regulation, women’s health, and biology

et al. 2023

View full text Add to dashboard Cite

The U.S. Food and Drug Administration’s (FDA) 2013 decision to lower recommended Ambien dosing for women has been widely cited as a hallmark example of the importance of sex differences in biomedicine. Using regulatory documents, scientific publications, and media coverage, this article analyzes the making of this highly influential and mobile ‘sex-difference fact’. As we show, the FDA’s decision was a contingent outcome of the drug approval process. Attending to how a contested sex-difference fact came to anchor elite women’s health advocacy, this article excavates the role of regulatory processes, advocacy groups, and the media in producing perceptions of scientific agreement while foreclosing ongoing debate, ultimately enabling the stabilization of a binary, biological sex-difference fact and the distancing of this fact from its conditions of construction.

show abstract

Section: The Fda Recommendationmentioning

confidence: 99%